Metrics Contract Services: Stephanie Emory, associate director of pharmaceutical development
Metrics Contract Services (the CDMO division of Mayne Pharma) has named Stephanie Emory associate director of pharmaceutical development. In that role, Emory will oversee a team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials, then scale up and support the validation and commercialization of those products.
Brad Gold, vice president of pharmaceutical development, said of Emory, “Her diverse skill sets will enhance our product development expertise as well as increase productivity by ensuring the efficient management of resources. She will be an effective and strategic leader who will help manage a broad spectrum of vital projects.”
